Plasma agmatine and platelet imidazoline receptors in depression

Annals of the New York Academy of Sciences

Volumn 881, Issue , 1999, Pages 445-451

  Halaris, Angelos ^a   Zhu, He ^a   Feng, Yengzheng ^a   Piletz, John E ^a,b  

^a UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MISSISSIPPI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGMATINE; AMFEBUTAMONE; ANTIDEPRESSANT AGENT; IMIDAZOLINE I1 RECEPTOR; IMIDAZOLINE RECEPTOR;

ADULT; CLINICAL ARTICLE; CONFERENCE PAPER; CONTROLLED STUDY; DEPRESSION; FEMALE; HUMAN; MALE; PLASMA; THROMBOCYTE;

EID: 0032806929     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1999.tb09392.x     Document Type: Conference Paper

References (24)

1. Bousquet, P., J. Feldman & J. Schwartz. 1984. Central cardiovascular effects of α-adrenergic drugs: Differences between catecholamines and imidazolines. J. Pharmacol. Exp. Ther. 230: 232-236.
2. 2 adrenoceptors in the human central nervous system. Neuroscience 59: 589-598.
3. 1-imidazoline receptors: Definition, characterization, distribution and transmembrane signalling. Ann. N.Y. Acad. Sci. 763: 22-42.
4. Parini, A., C. G. Moudanos, N. Pizzinat & S. M. Laniers. 1996. The elusive family of imidazoline binding sites. Trends Pharmacol. Sci. 17: 13-16.
5. 2-adrenergic receptors: Implications for depression. CRC Crit. Rev. Neurobiol. 9: 29-66.
6. Li, G., S. Regunathan, C. J. Barrow, J. Eshraghi, R. Cooper & D. J. Reis. 1994. Agmatine: An endogenous clonidine-displacing substance in the brain. Science 263: 966-969.
7. Piletz, J. E. & K. Slettens. 1993. Nonadrenergic imidazoline binding sites on human platelets. J. Pharmacol. Exp. Ther. 267: 1493-1502.
8. Garcia-Sevilla, J. A., P. V. Escriba, M. Sastre, C. Walzer, X. Busquets, G. Jaquet, D. J. Reis & J. Guimons. 1996. Immunodetection and quantitation of imidazoline receptor proteins in platelets of patients with major depression and in brains of suicide victims. Arch. Gen. Psychiatry 53: 803-810.
9. Ivanov, T., Y. Feng, H. Wang, S. Regunathan, D. J. Reis, D. N. Chikkala, P. Gupta, J. C. Jones & J. E. Piletz. 1998. Imidazoline receptor proteins are regulated in platelet-precursor MEG-01 cells by agonists and antagonists. J. Psychiatric Res. 32: 65-79.
10. 1-imidazoline binding sites are elevated in depression but not in generalized anxiety disorder. J. Psychiatric Res. 30: 147-168.
11. 2 adrenergic binding in platelets of women with dysphoric premenstrual syndromes. Biol. Psychiatry 34: 676-686.
12. Garcia-Sevilla, J. A., P. V. Escriba, A. Ozaita, C. Walzer & J. Guimons. 1998. Density of imidazoline receptors in platelets of euthymic patients with bipolar affective disorder and in brains of lithum-treated rats. Biol. Psychiatry 43: 616-618.
13. 1 imidazoline receptors in rat brainstem. Life Sci. 61: 1973-1983.
14. Raddatz, R., A. Parini & S. M. Laniers. 1997. Localization of the imidazoline binding domain on monoamine oxidase B. Mol. Pharmacol. 52: 549-553.
15. Feighner, J. P., E. A. Gardner, J. A. Johnston, S. R. Batey, M. A. Khayrallah, J. A. Ascher & C. G. Lineberry. 1991. Double-blind comparison of bupropion and fluoxetine in depressed outpatients. J. Clin. Psychiatry 52: 329-335.
16. Lineberry, C. G., J. A. Johnston, R. N. Raymond, B. Samara, J. P. Feighner, N. E. Harto, R. P. J. Granacher, R. H. Weisler, J. S. Carman & W. E. Boyers. 1990. A fixed-dose (300 mg) efficacy study of bupropion and placebo in depressed outpatients. J. Clin. Psychiatry 51: 194-199.
17. Ascher, J. A., J. O. Cole, J.-N. Colin, J. P. Feighner, R. M. Ferris, H. C. Fibiger, R. N. Golden, P. Martin, W. Z. Potter, E. Richelson & F. Sulser. 1995. Bupropion: A review of its mechanism of antidepressant activity. J. Clin. Psychiatry 56: 395-401.
18. Ferris, R. M., B. R. Cooper & R. A. Maxwell. 1983. Studies of bupropion's mechanism of antidepressant activity. J. Clin. Psychiatry 44: 5(Sec.2): 74-78.
19. Zhu, H., A. Halaris, S. Madakasira, P. Pazzaglia, N. Goldman, L. DeVane, M. Andrew, D. Reis & J. E. Piletz. 1998. Effect of bupropion on immunodensity of putative imidazoline receptors on platelets of depressed patients. J. Psychiatric Res. In press.
20. Hamilton, M. 1967. Development of a rating scale for primary depression. Br. J. Social Clin. Psychol. 6: 278-296.
21. Corash, L. 1980. Platelet heterogeneity: Relevance to the use of platelets to study psychiatric disorders. Schizo. Bull. 6: 254-258.
22. Feng, Y., A. E. Halaris & J. E. Piletz. 1997. Determination of agmatine in brain and plasma using high-performance liquid chromatography with fluorescence detection. J. Chromat. B: Biomed. Appl. 691/2: 277-286.
23. Ivanov, T. R., H. Zhu, S. Regunathan, D. J. Reis, M. Dontenwill, C. Vonthron, P. Bousquet & J. E. Piletz. 1998. Co-detection by two imidazoline receptor protein antiscra of a novel 85 kilodalton protein. Biochem. Pharmacol. 55: 649-655.
24. Sweet, R. A., B. G. Pollock, M. Kirshner, B. Wright, L. P. Altieri & C. L. DeVane. 1995. Pharmacokinetics of single- and multiple-dose bupropion in elderly patients with depression. J. Clin. Pharmacol. 35: 876-884.